Other
Obese
1
Pipeline Programs↗
6
Active Trials↗
14
Companies Involved↗
Obese is an early-stage landscape with 1 program across 14 companies. The most active players are Eli Lilly, Merck & Co., Rhythm Pharmaceuticals.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 11
Phase 2
No programs
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
64
clinical trials
Completed50 · 78%
Unknown status4 · 6%
Recruiting3 · 5%
Withdrawn2 · 3%
Not yet recruiting2 · 3%
Terminated2 · 3%
Other1 · 2%
Clinical Trials
Trial Activity
64 trials
Can Fat-Burning Shots Boost Fertility? Comparing Weight-Loss Injections vs. Healthy Habits for Obese Men With Low Sperm Health
Not yet recruiting·FFirst Affiliated Hospital of Wenzhou Medical University·Phase 2·NCT07179120·180 enrolled
Pharmacokinetics of Ceftaroline in Normal and Obese Subjects
Completed·—·Phase 1·NCT01648127·32 enrolled
Pharmacokinetics Of Tigecycline In Morbidly Obese Subjects
Completed·—·Phase 4·NCT01560143·12 enrolled
Page 1 of 5
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)